Author Correction: Genomic characterization of metastatic breast cancers

François Bertucci^#¹, Charlotte K Y Ng^#^{2

3

4}, Anne Patsouris^#^{5

6}, Nathalie Droin^{7

8

9}, Salvatore Piscuoglio^{2

3}, Nadine Carbuccia¹⁰, Jean Charles Soria^{11

12}, Alicia Tran Dien¹³, Yahia Adnani¹³, Maud Kamal¹⁴, Séverine Garnier¹⁰, Guillaume Meurice¹³, Marta Jimenez¹⁵, Semih Dogan¹⁶, Benjamin Verret¹⁶, Max Chaffanet¹⁰, Thomas Bachelot¹⁷, Mario Campone^{5

6}, Claudia Lefeuvre¹⁸, Herve Bonnefoi¹⁹, Florence Dalenc²⁰, Alexandra Jacquet¹⁵, Maria R De Filippo², Naveen Babbar²¹, Daniel Birnbaum¹⁰, Thomas Filleron²⁰, Christophe Le Tourneau^{22

23

24}, Fabrice André^{25

26

27}

Affiliations

¹ CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France. fandre@igr.fr.
² Institute of Pathology, University Hospital Basel, Basel, Switzerland.
³ Clarunis, Department of Biomedicine, University of Basel, Basel, Switzerland.
⁴ Department for BioMedical Research, University of Bern, Bern, Switzerland.
⁵ Inserm, U1232, Nantes, France.
⁶ Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, France.
⁷ Genomic Core Facility UMS AMMICA Gustave Roussy Cancer Campus, Villejuif, France.
⁸ INSERM, US23, Villejuif, France.
⁹ CNRS, UMS3665, Villejuif, France.
¹⁰ CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France.
¹¹ Université Paris Sud, Orsay, France.
¹² Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.
¹³ Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Department of Translational Research, Institut Curie, Saint-Cloud, France.
¹⁵ Unicancer, Paris, France.
¹⁶ Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.
¹⁷ Centre Léon Bérard, Lyon, France.
¹⁸ Centre Eugène Marquis, Rennes, France.
¹⁹ Institut Bergonié, Bordeaux, France.
²⁰ Institut Claudius-Regaud, IUCT-oncopôle, Toulouse, France.
²¹ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
²² Department of Drug Development and Innovation, Institut Curie, Saint-Cloud, France.
²³ INSERM U900, Saint-Cloud, France.
²⁴ Versailles Saint Quentin en Yvelines University, Montigny le Bretonneux, France.
²⁵ Université Paris Sud, Orsay, France. fandre@igr.fr.
²⁶ Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France. fandre@igr.fr.
²⁷ Department of Medical Oncology, Gustave Roussy, Villejuif, France. fandre@igr.fr.

^# Contributed equally.

PMID: 31308536
DOI: 10.1038/s41586-019-1380-3

Published Erratum

Author Correction: Genomic characterization of metastatic breast cancers

François Bertucci et al. Nature. 2019 Aug.

. 2019 Aug;572(7767):E7.

doi: 10.1038/s41586-019-1380-3.

Authors

Affiliations

¹ CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France. fandre@igr.fr.
² Institute of Pathology, University Hospital Basel, Basel, Switzerland.
³ Clarunis, Department of Biomedicine, University of Basel, Basel, Switzerland.
⁴ Department for BioMedical Research, University of Bern, Bern, Switzerland.
⁵ Inserm, U1232, Nantes, France.
⁶ Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, France.
⁷ Genomic Core Facility UMS AMMICA Gustave Roussy Cancer Campus, Villejuif, France.
⁸ INSERM, US23, Villejuif, France.
⁹ CNRS, UMS3665, Villejuif, France.
¹⁰ CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France.
¹¹ Université Paris Sud, Orsay, France.
¹² Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.
¹³ Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Department of Translational Research, Institut Curie, Saint-Cloud, France.
¹⁵ Unicancer, Paris, France.
¹⁶ Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.
¹⁷ Centre Léon Bérard, Lyon, France.
¹⁸ Centre Eugène Marquis, Rennes, France.
¹⁹ Institut Bergonié, Bordeaux, France.
²⁰ Institut Claudius-Regaud, IUCT-oncopôle, Toulouse, France.
²¹ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
²² Department of Drug Development and Innovation, Institut Curie, Saint-Cloud, France.
²³ INSERM U900, Saint-Cloud, France.
²⁴ Versailles Saint Quentin en Yvelines University, Montigny le Bretonneux, France.
²⁵ Université Paris Sud, Orsay, France. fandre@igr.fr.
²⁶ Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France. fandre@igr.fr.
²⁷ Department of Medical Oncology, Gustave Roussy, Villejuif, France. fandre@igr.fr.

^# Contributed equally.

PMID: 31308536
DOI: 10.1038/s41586-019-1380-3

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Genomic characterization of metastatic breast cancers.
Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F. Bertucci F, et al. Nature. 2019 May;569(7757):560-564. doi: 10.1038/s41586-019-1056-z. Epub 2019 May 22. Nature. 2019. PMID: 31118521

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Genomic characterization of metastatic breast cancers

Affiliations

Author Correction: Genomic characterization of metastatic breast cancers

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources